Suppr超能文献

5-HT1A 受体激动剂急性和重复给药对大鼠脑内 5-羟色胺(5-HT)释放的影响。

Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.

作者信息

Sharp T, McQuade R, Bramwell S, Hjorth S

机构信息

MRC Clinical Pharmacology Unit, Radcliffe Infirmary, Oxford, UK.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):339-46. doi: 10.1007/BF00171331.

Abstract
  1. Electrophysiological measurements of 5-HT neuronal activity report that repeated administration of 5-HT1A receptor agonists leads to desensitization of the 5-HT1A autoreceptor but this has not yet been detected in measurements of brain 5-HT synthesis or metabolism. Here we have determined the effect of repeated administration of 5-HT1A receptor agonists on brain 5-HT release using microdialysis. 2. Acute administration of the 5-HT1A receptor agonists buspirone (0.1-5 mg/kg s.c.) and ipsapirone (0.03-3 mg/kg s.c.) caused a dose-dependent decrease in 5-HT output in ventral hippocampus of the chloral hydrate anaesthetized rat. 3. The 5-HT response to buspirone (0.1 and 0.5 mg/kg s.c.) and ipsapirone (0.3 mg/kg s.c.) was significantly inhibited by pre-treatment with the 5-HT1/beta-adrenoceptor antagonist pindolol (8-16 mg/kg s.c.). The 5-HT response to buspirone (0.1 mg/kg s.c.) and ipsapirone (0.3 mg/kg s.c.) was not blocked by pretreatment with a combination of the beta 1 and beta 2-adrenoceptor antagonists metoprolol and ICI 118,551 (4 mg/kg s.c.). 4. The effect of an acute challenge of buspirone (0.5 mg/kg s.c.) on 5-HT output in ventral hippocampus was not attenuated in rats treated twice daily for 14 days with 0.5 or 5 mg/kg s.c. buspirone compared to saline-injected controls. Similarly, the decrease in 5-HT induced by an acute challenge of ipsapirone (0.5 mg/kg s.c.) was not attenuated in rats treated twice daily for 14 days with 5 mg/kg s.c. ipsapirone.(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 对5-羟色胺(5-HT)神经元活动的电生理测量报告称,重复给予5-HT1A受体激动剂会导致5-HT1A自身受体脱敏,但在脑5-HT合成或代谢的测量中尚未检测到这种情况。在此,我们使用微透析法确定了重复给予5-HT1A受体激动剂对脑5-HT释放的影响。2. 急性给予5-HT1A受体激动剂丁螺环酮(0.1 - 5毫克/千克,皮下注射)和伊沙匹隆(0.03 - 3毫克/千克,皮下注射)会使水合氯醛麻醉大鼠腹侧海马体中的5-HT输出呈剂量依赖性降低。3. 用5-HT1/β-肾上腺素能受体拮抗剂吲哚洛尔(8 - 16毫克/千克,皮下注射)预处理可显著抑制对丁螺环酮(0.1和0.5毫克/千克,皮下注射)和伊沙匹隆(0.3毫克/千克,皮下注射)的5-HT反应。用β1和β2-肾上腺素能受体拮抗剂美托洛尔和ICI 118,551(4毫克/千克,皮下注射)联合预处理不会阻断对丁螺环酮(0.1毫克/千克,皮下注射)和伊沙匹隆(0.3毫克/千克,皮下注射)的5-HT反应。4. 与注射生理盐水的对照组相比,每天两次、连续14天用0.5或5毫克/千克皮下注射丁螺环酮处理的大鼠,丁螺环酮(0.5毫克/千克,皮下注射)急性激发对腹侧海马体5-HT输出的影响并未减弱。同样,每天两次、连续14天用5毫克/千克皮下注射伊沙匹隆处理的大鼠,伊沙匹隆(0.5毫克/千克,皮下注射)急性激发诱导的5-HT降低也未减弱。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验